{"id":"W2521999181","doi":"10.1182/blood.v112.11.1723.1723","title":"Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Lenalidomide; Medicine; Thalidomide; Regimen; Multiple myeloma; Internal medicine; Cyclophosphamide; Prednisone; Gastroenterology; Surgery; Bortezomib; Transplantation; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00210043,0.001864276,0.001656088,0.0004028484,0.0003691725,0.0008899112,0.0009588074,0.001095746,0.003555713],"category_scores_gemma":[0.0009047605,0.0006215696,0.001001513,0.0003909894,0.001130355,0.0006428856,0.0003913754,0.003698218,0.0008598227],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009194884,"about_ca_system_score_gemma":0.001041912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008376748,"about_ca_topic_score_gemma":0.001972684,"domain_scores_codex":[0.9993842,0.0003702838,0.00002542558,0.00007691491,0.00003805876,0.0001052432],"domain_scores_gemma":[0.999194,0.0001356113,0.0001417683,0.0000643145,0.00002828582,0.0004361132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8510087,0.05756997,0.006222909,0.0005306254,0.0008405331,0.0003257513,0.0002151195,0.001506892,0.02133383,0.0003881113,0.005329395,0.05472824],"study_design_scores_gemma":[0.7585449,0.2304706,0.00635964,0.00002291102,0.0002240235,0.0001925547,0.0000297672,0.0008445848,0.001451864,0.0001532085,0.001690835,0.00001505634],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897026,0.002018329,0.0004448071,0.0007855693,0.0002253316,0.003486209,0.001046357,0.00009864101,0.002192127],"genre_scores_gemma":[0.9871546,0.00151247,0.001578675,0.001284253,0.0003341307,0.002637153,0.002716679,0.00002662206,0.002755386],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003555713,"threshold_uncertainty_score":0.01189506,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03098484581053437,"score_gpt":0.2908620072020939,"score_spread":0.2598771613915595,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}